Texas is moving forward with clinical trials for ibogaine psychedelic. The state's decision comes after efforts to find a drug company to partner with were unsuccessful. Details about the trials, including their scope and timeline, are not specified in the initial report.

For more information on the clinical trials, readers can refer to the source, KXXV, which may provide further updates and details as they become available.